FDA
approval
· 2015-03-03
FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA has approved Glenmark Pharmaceuticals Inc., USA's supplemental application for Lithium carbonate (generic) under ANDA 079139. The approval updates the statu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LITHIUM CARBONATE (LITHIUM CARBONATE)